A 2024 multi-omic analysis published in Blood found that specific TP53 hotspot mutations (R175H, R273H) were associated with enhanced oxidative phosphorylation and a higher prevalence of primitive leukemia stem and progenitor states (101). This evidence concerns the gene TP53 and leukemia.